Zydus receives final approval from US FDA for Bortezomib for injection
Bortezomib for injection is used to treat certain types of cancer such as multiple myeloma and mantle cell lymphoma
Sign in
Sign in
Recover your password.
A password will be e-mailed to you.
Browsing Category
Drug approvals
US FDA approves Bristol Myers’ oral heart disease drug
The company said the drug comes with a boxed warning for the risk of heart failure
Alembic Pharma receives US FDA tentative approval for Ivabradine tablets
The tentatively approved ANDA is therapeutically equivalent to the Reference Listed Drug (RLD) product Corlanor tablets, 5 mg and…
Zydus Lifesciences receives final approval from US FDA for Cyanocobalamin injection
The injection is used to treat and prevent lack of vitamin B12 that may be caused due to pernicious anaemia, certain diseases,…
Britain approves Valneva’s easy-to-store COVID shot
The shot is also the sixth COVID-19 vaccine to be approved in the UK
Aleor Dermaceuticals receives US FDA final approval for Lidocaine and Prilocaine cream
The approved ANDA is therapeutically equivalent to the Reference Listed Drug (RLD) product EMLA Cream, 2.5%/2.5%, of Teva Branded…
US FDA approves Gilead cell therapy for earlier lymphoma
The one-time treatment was initially approved in 2017 for patients with large B-cell lymphoma who did not respond to at least two…
Biocon Biologics’ partner receives positive EU CHMP opinion for biosimilar human insulin for IV…
Celerity Pharma uses Biocon Biologics’ insulin drug substance to develop the product
FDA authorises second booster of Pfizer/BioNTech and Moderna COVID shots
The agency said the new boosters - a fourth round of shots for most vaccine recipients - of the Pfizer Inc/BioNTech SE and Moderna…
US FDA approves Novo Nordisk’s Ozempic 2 mg to treat type-II diabetes
Ozempic demonstrated 2.1 per cent blood sugar reduction and also weight loss in adults with type-II diabetes with new 2 mg dose